Overview

Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
efficacy study in patients with moderate to severe plaque psoriasis.
Phase:
Phase 3
Details
Lead Sponsor:
Taro Pharmaceuticals USA
Treatments:
Desoximetasone